阿立哌唑治疗双相 I 障碍的急性期和维持期。
Aripiprazole in the acute and maintenance phase of bipolar I disorder.
机构信息
Southern Illinois University School of Medicine, Springfield, IL, USA.
出版信息
Ther Clin Risk Manag. 2012;8:1-6. doi: 10.2147/TCRM.S22579. Epub 2012 Jan 12.
Abstract
Bipolar affective disorder is a disabling illness with substantial morbidity and many management challenges. Traditional mood stabilizers such as lithium, valproate, and carbamazepine are often inadequate in controlling symptoms both during the acute and maintenance phase of treatment. Aripiprazole is a second-generation antipsychotic with a unique mechanism of action. Evidence suggests that it is effective in acute manic and mixed states. There are limited data to suggest its efficacy as a maintenance agent. Future studies will be needed to better define the role of aripiprazole relative to other traditional pharmacologic agents.
摘要
双相情感障碍是一种使人丧失能力的疾病，发病率高，管理方面存在诸多挑战。在急性和维持治疗阶段，传统心境稳定剂如锂盐、丙戊酸盐和卡马西平往往无法充分控制症状。阿立哌唑是一种具有独特作用机制的第二代抗精神病药。有证据表明，它在急性躁狂和混合状态中有效。关于其作为维持治疗药物的疗效，数据有限。需要进一步研究来更好地确定阿立哌唑相对于其他传统药物的作用。
相似文献
1
Aripiprazole in the acute and maintenance phase of bipolar I disorder.阿立哌唑治疗双相 I 障碍的急性期和维持期。
Ther Clin Risk Manag. 2012;8:1-6. doi: 10.2147/TCRM.S22579. Epub 2012 Jan 12.
2
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
3
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].青少年情绪稳定剂处方指南：文献综述
Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18.
4
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.阿立哌唑治疗双相抑郁的临床评价及双相障碍的维持治疗。
J Affect Disord. 2011 Jan;128 Suppl 1:S21-8. doi: 10.1016/S0165-0327(11)70005-2.
5
Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.在分层为指数躁狂或混合发作的双相 I 患者中，阿立哌唑与锂或丙戊酸盐联用预防躁狂或混合发作复发的疗效。
J Affect Disord. 2013 May;147(1-3):365-72. doi: 10.1016/j.jad.2012.11.042. Epub 2013 Jan 3.
6
Acute and maintenance treatment with mood stabilizers.使用心境稳定剂进行急性和维持治疗。
Int J Neuropsychopharmacol. 2003 Sep;6(3):269-75. doi: 10.1017/S1461145703003535.
7
Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.阿立哌唑治疗躁狂症急性期和双相情感障碍的长期治疗：意大利工作组的一项重要综述。
Clin Drug Investig. 2010;30(12):827-841. doi: 10.2165/11584270-000000000-00000.
8
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.阿立哌唑用于双相 I 型障碍的维持治疗：综述。
Clin Ther. 2010;32 Suppl 1:S32-8. doi: 10.1016/j.clinthera.2010.01.022.
9
Lithium for acute mania.用于急性躁狂症的锂盐。
Cochrane Database Syst Rev. 2019 Jun 1;6(6):CD004048. doi: 10.1002/14651858.CD004048.pub4.
10
Role of aripiprazole in treating mood disorders.阿立哌唑在治疗情绪障碍中的作用。
Expert Rev Neurother. 2006 Dec;6(12):1777-83. doi: 10.1586/14737175.6.12.1777.
引用本文的文献
1
Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy.维持双相情感障碍的情绪稳定：药物治疗的临床视角
Evid Based Ment Health. 2015 Feb;18(1):1-6. doi: 10.1136/eb-2014-101948. Epub 2014 Aug 27.
本文引用的文献
1
Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.双相情感障碍与其他慢性疾病的直接成本：基于雇主健康计划的分析。
Psychiatr Serv. 2011 Sep;62(9):1073-8. doi: 10.1176/ps.62.9.pss6209_1073.
2
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence.阿立哌唑用于双相情感障碍的维持治疗：现有证据的回顾。
Neuropsychiatr Dis Treat. 2011;7:319-23. doi: 10.2147/NDT.S13876. Epub 2011 May 25.
3
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.在锂或丙戊酸单药治疗反应不足的双相 I 障碍患者的长期治疗中，阿立哌唑辅助锂或丙戊酸的疗效：一项多中心、双盲、随机研究。
Bipolar Disord. 2011 Mar;13(2):133-44. doi: 10.1111/j.1399-5618.2011.00898.x.
4
Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.从单相重性抑郁障碍向双相障碍发展过程中的阈下轻躁狂症状。
Am J Psychiatry. 2011 Jan;168(1):40-8. doi: 10.1176/appi.ajp.2010.10030328. Epub 2010 Nov 15.
5
Challenges and solutions in developing new medications for Schizophrenia.开发治疗精神分裂症新药面临的挑战及解决方案。
J Clin Psychiatry. 2010 Oct;71(10):1391-9. doi: 10.4088/JCP.10064ah1yel.
6
Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.在国家共病调查再研究中具有亚阈值双相性的重度抑郁障碍。
Am J Psychiatry. 2010 Oct;167(10):1194-201. doi: 10.1176/appi.ajp.2010.09071011. Epub 2010 Aug 16.
7
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.评估阿立哌唑辅助锂/丙戊酸盐治疗双相情感障碍躁狂症的安全性、耐受性和有效性：一项为期 6 周双盲研究后的 46 周开放性扩展研究。
Curr Med Res Opin. 2010 Jun;26(6):1485-96. doi: 10.1185/03007991003779380.
8
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.作为阈下双相性结果的《精神疾病诊断与统计手册》第四版重性抑郁障碍的异质性
Arch Gen Psychiatry. 2009 Dec;66(12):1341-52. doi: 10.1001/archgenpsychiatry.2009.158.
9
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.阿立哌唑单药治疗急性躁狂症：一项为期12周的随机、安慰剂和氟哌啶醇对照研究。
Br J Psychiatry. 2009 Jan;194(1):40-8. doi: 10.1192/bjp.bp.108.049965.
10
Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability.物质使用障碍住院患者中情绪不稳定者双相情感障碍的过度诊断
J Clin Psychiatry. 2008 Nov;69(11):1751-7. doi: 10.4088/jcp.v69n1110. Epub 2008 Aug 12.
Zotero 插件